Michael Schatz1, Robert S Zeiger2, Su-Jau Yang3, Andrew G Weinstein4, Wansu Chen3, Renee N Saris-Baglama5, Diane M Turner-Bowker6. 1. Department of Allergy, Kaiser Permanente Medical Center, San Diego and Los Angeles, Calif; Department of Research and Evaluation, Kaiser Permanente Medical Center, San Diego and Los Angeles, Calif. Electronic address: michael.x.schatz@kp.org. 2. Department of Allergy, Kaiser Permanente Medical Center, San Diego and Los Angeles, Calif; Department of Research and Evaluation, Kaiser Permanente Medical Center, San Diego and Los Angeles, Calif. 3. Department of Research and Evaluation, Kaiser Permanente Medical Center, San Diego and Los Angeles, Calif. 4. Department of Allergy-Immunology, Thomas Jefferson Medical College, Wilmington, Del. 5. Datacorp, Smithfield, RI. 6. ERT, Pittsburgh, Pa.
Abstract
BACKGROUND: Asthma medication adherence is related to better asthma outcomes, but identification of suboptimal patient adherence behavior is not standardized in clinical settings. OBJECTIVE: [corrected] The purpose of this study was to develop a practical questionnaire that reflects nonadherence risk and identifies potential adherence barriers. METHODS: A questionnaire that included 20 potential adherence questions was completed by 420 adult patients with asthma who filled a prescription for an inhaled corticosteroid (ICS) and a short-acting beta agonist (SABA) in the previous 6 months. Questions without substantial floor or ceiling effects that were significantly related to self-reported low adherence or previous ICS canister dispensings were identified. Internal consistency reliability was tested by Cronbach α. Relationships of these questions to Asthma Control Test scores, future percent of days covered for ICS dispensings, and future asthma exacerbations and SABA dispensings were determined. RESULTS: Five final questions were identified: following "my medication plan," forgetting, not "needing" the medications, side effects, and cost. Low internal consistency reliability (<0.50) suggested items should not be summarized by a single score. All five questions were related to Asthma Control Test scores. Following the medication plan, forgetting, and not needing medication were significantly related to prospective percent of days covered. Side effects were related to subsequent SABA and oral corticosteroid dispensings, and cost was significantly related to oral corticosteroid dispensings. CONCLUSIONS: We identified five questions related to other measures of adherence and to asthma control that can be used clinically to identify patients at risk of nonadherence and the specific adherence barriers involved.
BACKGROUND: Asthma medication adherence is related to better asthma outcomes, but identification of suboptimal patient adherence behavior is not standardized in clinical settings. OBJECTIVE: [corrected] The purpose of this study was to develop a practical questionnaire that reflects nonadherence risk and identifies potential adherence barriers. METHODS: A questionnaire that included 20 potential adherence questions was completed by 420 adult patients with asthma who filled a prescription for an inhaled corticosteroid (ICS) and a short-acting beta agonist (SABA) in the previous 6 months. Questions without substantial floor or ceiling effects that were significantly related to self-reported low adherence or previous ICS canister dispensings were identified. Internal consistency reliability was tested by Cronbach α. Relationships of these questions to Asthma Control Test scores, future percent of days covered for ICS dispensings, and future asthma exacerbations and SABA dispensings were determined. RESULTS: Five final questions were identified: following "my medication plan," forgetting, not "needing" the medications, side effects, and cost. Low internal consistency reliability (<0.50) suggested items should not be summarized by a single score. All five questions were related to Asthma Control Test scores. Following the medication plan, forgetting, and not needing medication were significantly related to prospective percent of days covered. Side effects were related to subsequent SABA and oral corticosteroid dispensings, and cost was significantly related to oral corticosteroid dispensings. CONCLUSIONS: We identified five questions related to other measures of adherence and to asthma control that can be used clinically to identify patients at risk of nonadherence and the specific adherence barriers involved.
Authors: Peter J Cvietusa; Glenn K Goodrich; Jo Ann Shoup; David A Steffen; Cathy Tacinas; Nicole M Wagner; Courtney B Anderson; Debra P Ritzwoller; Bruce G Bender Journal: J Allergy Clin Immunol Pract Date: 2018-09-07
Authors: Yu Heng Kwan; Livia Jia Yi Oo; Dionne Hui Fang Loh; Truls Østbye; Lian Leng Low; Hayden Barry Bosworth; Julian Thumboo; Jie Kie Phang; Si Dun Weng; Dan V Blalock; Eng Hui Chew; Kai Zhen Yap; Corrinne Yong Koon Tan; Sungwon Yoon; Warren Fong Journal: J Med Internet Res Date: 2020-10-08 Impact factor: 5.428
Authors: Yu Heng Kwan; Si Dun Weng; Dionne Hui Fang Loh; Truls Østbye; Lian Leng Low; Hayden Barry Bosworth; Julian Thumboo; Jie Kie Phang; Livia Jia Yi Oo; Dan V Blalock; Eng Hui Chew; Kai Zhen Yap; Corrinne Yong Koon Tan; Sungwon Yoon; Warren Fong Journal: J Med Internet Res Date: 2020-10-09 Impact factor: 5.428
Authors: Sarah Bentley; Lucy Morgan; Elizabeth Exall; Rob Arbuckle; Rebecca C Rossom; Nicholas Roche; Kamlesh Khunti; Victoria Higgins; James Piercy Journal: Patient Prefer Adherence Date: 2022-09-15 Impact factor: 2.314
Authors: Mary A De Vera; Mohsen Sadatsafavi; Nicole W Tsao; Larry D Lynd; Richard Lester; Louise Gastonguay; Jessica Galo; J Mark FitzGerald; Penelope Brasher; Carlo A Marra Journal: Trials Date: 2014-12-13 Impact factor: 2.279